MRFRの分析によると、抗感染症薬市場規模は2022年に118.15 (10億ドル) と推定されました。この市場は2023年の120.99 (10億ドル) から2032年までに150.0 (10億ドル) に成長し、予測期間中 (2024-2032) のCAGRは約2.41%になると予想されます。
目次
Table of Contents
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. Antiinfective Drug Market, BY Drug Classification (USD Billion)
6.1. Antibiotics
6.2. Antivirals
6.3. Antifungals
6.4. Antiparasitics
7. Antiinfective Drug Market, BY Administration Route (USD Billion)
7.1. Oral
7.2. Injectable
7.3. Topical
7.4. Intravenous
8. Antiinfective Drug Market, BY Therapeutic Application (USD Billion)
8.1. Infectious Diseases
8.2. Preventative Care
8.3. Surgical Prophylaxis
9. Antiinfective Drug Market, BY Formulation Type (USD Billion)
9.1. Generic Drugs
9.2. Branded Drugs
10. Antiinfective Drug Market, BY End User (USD Billion)
10.1. Hospitals
10.2. Clinics
10.3. Pharmacies
10.4. Home Care Settings
11. Antiinfective Drug Market, BY Regional (USD Billion)
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. Germany
11.2.2. UK
11.2.3. France
11.2.4. Russia
11.2.5. Italy
11.2.6. Spain
11.2.7. Rest of Europe
11.3. APAC
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Malaysia
11.3.6. Thailand
11.3.7. Indonesia
11.3.8. Rest of APAC
11.4. South America
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of South America
11.5. MEA
11.5.1. GCC Countries
11.5.2. South Africa
11.5.3. Rest of MEA
12. Competitive Landscape
12.1. Overview
12.2. Competitive Analysis
12.3. Market share Analysis
12.4. Major Growth Strategy in the Antiinfective Drug Market
12.5. Competitive Benchmarking
12.6. Leading Players in Terms of Number of Developments in the Antiinfective Drug Market
12.7. Key developments and growth strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales and Operating Income
12.8.2. Major Players R&D Expenditure. 2023
13. Company Profiles
13.1. Roche
13.1.1. Financial Overview
13.1.2. Products Offered
13.1.3. Key Developments
13.1.4. SWOT Analysis
13.1.5. Key Strategies
13.2. AstraZeneca
13.2.1. Financial Overview
13.2.2. Products Offered
13.2.3. Key Developments
13.2.4. SWOT Analysis
13.2.5. Key Strategies
13.3. Sanofi
13.3.1. Financial Overview
13.3.2. Products Offered
13.3.3. Key Developments
13.3.4. SWOT Analysis
13.3.5. Key Strategies
13.4. Eli Lilly and Company
13.4.1. Financial Overview
13.4.2. Products Offered
13.4.3. Key Developments
13.4.4. SWOT Analysis
13.4.5. Key Strategies
13.5. Gilead Sciences
13.5.1. Financial Overview
13.5.2. Products Offered
13.5.3. Key Developments
13.5.4. SWOT Analysis
13.5.5. Key Strategies
13.6. Hikma Pharmaceuticals
13.6.1. Financial Overview
13.6.2. Products Offered
13.6.3. Key Developments
13.6.4. SWOT Analysis
13.6.5. Key Strategies
13.7. Amgen
13.7.1. Financial Overview
13.7.2. Products Offered
13.7.3. Key Developments
13.7.4. SWOT Analysis
13.7.5. Key Strategies
13.8. Pfizer
13.8.1. Financial Overview
13.8.2. Products Offered
13.8.3. Key Developments
13.8.4. SWOT Analysis
13.8.5. Key Strategies
13.9. Johnson Johnson
13.9.1. Financial Overview
13.9.2. Products Offered
13.9.3. Key Developments
13.9.4. SWOT Analysis
13.9.5. Key Strategies
13.10. BristolMyers Squibb
13.10.1. Financial Overview
13.10.2. Products Offered
13.10.3. Key Developments
13.10.4. SWOT Analysis
13.10.5. Key Strategies
13.11. Merck Co.
13.11.1. Financial Overview
13.11.2. Products Offered
13.11.3. Key Developments
13.11.4. SWOT Analysis
13.11.5. Key Strategies
13.12. GlaxoSmithKline
13.12.1. Financial Overview
13.12.2. Products Offered
13.12.3. Key Developments
13.12.4. SWOT Analysis
13.12.5. Key Strategies
13.13. AbbVie
13.13.1. Financial Overview
13.13.2. Products Offered
13.13.3. Key Developments
13.13.4. SWOT Analysis
13.13.5. Key Strategies
13.14. Novartis
13.14.1. Financial Overview
13.14.2. Products Offered
13.14.3. Key Developments
13.14.4. SWOT Analysis
13.14.5. Key Strategies
13.15. Teva Pharmaceutical Industries
13.15.1. Financial Overview
13.15.2. Products Offered
13.15.3. Key Developments
13.15.4. SWOT Analysis
13.15.5. Key Strategies
13.16. Mylan
13.16.1. Financial Overview
13.16.2. Products Offered
13.16.3. Key Developments
13.16.4. SWOT Analysis
13.16.5. Key Strategies
14. Appendix
14.1. References
14.2. Related Reports
LIST Of tables
Table 1. LIST OF ASSUMPTIONS
Table 2. North America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 3. North America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 4. North America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 5. North America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 6. North America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 7. North America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 8. US Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 9. US Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 10. US Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 11. US Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 12. US Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 13. US Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 14. Canada Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 15. Canada Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 16. Canada Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 17. Canada Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 18. Canada Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 19. Canada Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 20. Europe Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 21. Europe Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 22. Europe Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 23. Europe Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 24. Europe Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 25. Europe Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 26. Germany Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 27. Germany Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 28. Germany Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 29. Germany Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 30. Germany Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 31. Germany Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 32. UK Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 33. UK Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 34. UK Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 35. UK Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 36. UK Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 37. UK Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 38. France Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 39. France Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 40. France Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 41. France Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 42. France Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 43. France Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 44. Russia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 45. Russia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 46. Russia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 47. Russia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 48. Russia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 49. Russia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 50. Italy Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 51. Italy Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 52. Italy Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 53. Italy Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 54. Italy Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 55. Italy Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 56. Spain Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 57. Spain Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 58. Spain Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 59. Spain Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 60. Spain Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 61. Spain Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 62. Rest of Europe Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 63. Rest of Europe Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 64. Rest of Europe Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 65. Rest of Europe Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 66. Rest of Europe Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 67. Rest of Europe Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 68. APAC Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 69. APAC Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 70. APAC Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 71. APAC Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 72. APAC Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 73. APAC Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 74. China Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 75. China Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 76. China Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 77. China Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 78. China Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 79. China Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 80. India Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 81. India Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 82. India Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 83. India Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 84. India Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 85. India Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 86. Japan Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 87. Japan Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 88. Japan Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 89. Japan Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 90. Japan Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 91. Japan Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 92. South Korea Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 93. South Korea Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 94. South Korea Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 95. South Korea Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 96. South Korea Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 97. South Korea Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 98. Malaysia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 99. Malaysia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 100. Malaysia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 101. Malaysia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 102. Malaysia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 103. Malaysia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 104. Thailand Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 105. Thailand Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 106. Thailand Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 107. Thailand Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 108. Thailand Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 109. Thailand Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 110. Indonesia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 111. Indonesia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 112. Indonesia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 113. Indonesia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 114. Indonesia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 115. Indonesia Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 116. Rest of APAC Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 117. Rest of APAC Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 118. Rest of APAC Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 119. Rest of APAC Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 120. Rest of APAC Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 121. Rest of APAC Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 122. South America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 123. South America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 124. South America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 125. South America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 126. South America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 127. South America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 128. Brazil Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 129. Brazil Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 130. Brazil Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 131. Brazil Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 132. Brazil Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 133. Brazil Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 134. Mexico Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 135. Mexico Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 136. Mexico Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 137. Mexico Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 138. Mexico Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 139. Mexico Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 140. Argentina Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 141. Argentina Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 142. Argentina Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 143. Argentina Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 144. Argentina Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 145. Argentina Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 146. Rest of South America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 147. Rest of South America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 148. Rest of South America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 149. Rest of South America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 150. Rest of South America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 151. Rest of South America Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 152. MEA Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 153. MEA Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 154. MEA Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 155. MEA Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 156. MEA Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 157. MEA Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 158. GCC Countries Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 159. GCC Countries Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 160. GCC Countries Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 161. GCC Countries Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 162. GCC Countries Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 163. GCC Countries Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 164. South Africa Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 165. South Africa Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 166. South Africa Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 167. South Africa Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 168. South Africa Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 169. South Africa Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 170. Rest of MEA Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY DRUG CLASSIFICATION, 2019-2032 (USD Billions)
Table 171. Rest of MEA Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD Billions)
Table 172. Rest of MEA Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC APPLICATION, 2019-2032 (USD Billions)
Table 173. Rest of MEA Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2032 (USD Billions)
Table 174. Rest of MEA Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD Billions)
Table 175. Rest of MEA Antiinfective Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD Billions)
Table 176. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
Table 177. ACQUISITION/PARTNERSHIP
LIST Of figures
Figure 1. MARKET SYNOPSIS
Figure 2. NORTH AMERICA ANTIINFECTIVE DRUG MARKET ANALYSIS
Figure 3. US ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 4. US ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 5. US ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 6. US ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 7. US ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 8. US ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 9. CANADA ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 10. CANADA ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 11. CANADA ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 12. CANADA ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 13. CANADA ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 14. CANADA ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 15. EUROPE ANTIINFECTIVE DRUG MARKET ANALYSIS
Figure 16. GERMANY ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 17. GERMANY ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 18. GERMANY ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 19. GERMANY ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 20. GERMANY ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 21. GERMANY ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 22. UK ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 23. UK ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 24. UK ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 25. UK ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 26. UK ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 27. UK ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 28. FRANCE ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 29. FRANCE ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 30. FRANCE ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 31. FRANCE ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 32. FRANCE ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 33. FRANCE ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 34. RUSSIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 35. RUSSIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 36. RUSSIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 37. RUSSIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 38. RUSSIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 39. RUSSIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 40. ITALY ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 41. ITALY ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 42. ITALY ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 43. ITALY ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 44. ITALY ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 45. ITALY ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 46. SPAIN ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 47. SPAIN ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 48. SPAIN ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 49. SPAIN ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 50. SPAIN ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 51. SPAIN ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 52. REST OF EUROPE ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 53. REST OF EUROPE ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 54. REST OF EUROPE ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 55. REST OF EUROPE ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 56. REST OF EUROPE ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 57. REST OF EUROPE ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 58. APAC ANTIINFECTIVE DRUG MARKET ANALYSIS
Figure 59. CHINA ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 60. CHINA ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 61. CHINA ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 62. CHINA ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 63. CHINA ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 64. CHINA ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 65. INDIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 66. INDIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 67. INDIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 68. INDIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 69. INDIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 70. INDIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 71. JAPAN ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 72. JAPAN ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 73. JAPAN ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 74. JAPAN ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 75. JAPAN ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 76. JAPAN ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 77. SOUTH KOREA ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 78. SOUTH KOREA ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 79. SOUTH KOREA ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 80. SOUTH KOREA ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 81. SOUTH KOREA ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 82. SOUTH KOREA ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 83. MALAYSIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 84. MALAYSIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 85. MALAYSIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 86. MALAYSIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 87. MALAYSIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 88. MALAYSIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 89. THAILAND ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 90. THAILAND ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 91. THAILAND ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 92. THAILAND ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 93. THAILAND ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 94. THAILAND ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 95. INDONESIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 96. INDONESIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 97. INDONESIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 98. INDONESIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 99. INDONESIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 100. INDONESIA ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 101. REST OF APAC ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 102. REST OF APAC ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 103. REST OF APAC ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 104. REST OF APAC ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 105. REST OF APAC ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 106. REST OF APAC ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 107. SOUTH AMERICA ANTIINFECTIVE DRUG MARKET ANALYSIS
Figure 108. BRAZIL ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 109. BRAZIL ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 110. BRAZIL ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 111. BRAZIL ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 112. BRAZIL ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 113. BRAZIL ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 114. MEXICO ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 115. MEXICO ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 116. MEXICO ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 117. MEXICO ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 118. MEXICO ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 119. MEXICO ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 120. ARGENTINA ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 121. ARGENTINA ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 122. ARGENTINA ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 123. ARGENTINA ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 124. ARGENTINA ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 125. ARGENTINA ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 126. REST OF SOUTH AMERICA ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 127. REST OF SOUTH AMERICA ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 128. REST OF SOUTH AMERICA ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 129. REST OF SOUTH AMERICA ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 130. REST OF SOUTH AMERICA ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 131. REST OF SOUTH AMERICA ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 132. MEA ANTIINFECTIVE DRUG MARKET ANALYSIS
Figure 133. GCC COUNTRIES ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 134. GCC COUNTRIES ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 135. GCC COUNTRIES ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 136. GCC COUNTRIES ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 137. GCC COUNTRIES ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 138. GCC COUNTRIES ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 139. SOUTH AFRICA ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 140. SOUTH AFRICA ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 141. SOUTH AFRICA ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 142. SOUTH AFRICA ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 143. SOUTH AFRICA ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 144. SOUTH AFRICA ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 145. REST OF MEA ANTIINFECTIVE DRUG MARKET ANALYSIS BY DRUG CLASSIFICATION
Figure 146. REST OF MEA ANTIINFECTIVE DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
Figure 147. REST OF MEA ANTIINFECTIVE DRUG MARKET ANALYSIS BY THERAPEUTIC APPLICATION
Figure 148. REST OF MEA ANTIINFECTIVE DRUG MARKET ANALYSIS BY FORMULATION TYPE
Figure 149. REST OF MEA ANTIINFECTIVE DRUG MARKET ANALYSIS BY END USER
Figure 150. REST OF MEA ANTIINFECTIVE DRUG MARKET ANALYSIS BY REGIONAL
Figure 151. KEY BUYING CRITERIA OF ANTIINFECTIVE DRUG MARKET
Figure 152. RESEARCH PROCESS OF MRFR
Figure 153. DRO ANALYSIS OF ANTIINFECTIVE DRUG MARKET
Figure 154. DRIVERS IMPACT ANALYSIS: ANTIINFECTIVE DRUG MARKET
Figure 155. RESTRAINTS IMPACT ANALYSIS: ANTIINFECTIVE DRUG MARKET
Figure 156. SUPPLY / VALUE CHAIN: ANTIINFECTIVE DRUG MARKET
Figure 157. ANTIINFECTIVE DRUG MARKET, BY DRUG CLASSIFICATION, 2024 (% SHARE)
Figure 158. ANTIINFECTIVE DRUG MARKET, BY DRUG CLASSIFICATION, 2019 TO 2032 (USD Billions)
Figure 159. ANTIINFECTIVE DRUG MARKET, BY ADMINISTRATION ROUTE, 2024 (% SHARE)
Figure 160. ANTIINFECTIVE DRUG MARKET, BY ADMINISTRATION ROUTE, 2019 TO 2032 (USD Billions)
Figure 161. ANTIINFECTIVE DRUG MARKET, BY THERAPEUTIC APPLICATION, 2024 (% SHARE)
Figure 162. ANTIINFECTIVE DRUG MARKET, BY THERAPEUTIC APPLICATION, 2019 TO 2032 (USD Billions)
Figure 163. ANTIINFECTIVE DRUG MARKET, BY FORMULATION TYPE, 2024 (% SHARE)
Figure 164. ANTIINFECTIVE DRUG MARKET, BY FORMULATION TYPE, 2019 TO 2032 (USD Billions)
Figure 165. ANTIINFECTIVE DRUG MARKET, BY END USER, 2024 (% SHARE)
Figure 166. ANTIINFECTIVE DRUG MARKET, BY END USER, 2019 TO 2032 (USD Billions)
Figure 167. ANTIINFECTIVE DRUG MARKET, BY REGIONAL, 2024 (% SHARE)
Figure 168. ANTIINFECTIVE DRUG MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
Figure 169. BENCHMARKING OF MAJOR COMPETITORS
